Meridian Cancer Causing Viruses Flyer

HPV DNA Test:

Lyo-Ready Genotyping Direct qPCR Urine Mix, 4x (MDX158) Meridian’s Lyo-Ready Genotyping Direct qPCR Urine is a 4x inhibitor-resistant mix designed for highly specific and sensitive amplification for genotyping sequence variants, even in the presence of PCR inhibitors found in crude urine samples, to give exceptional cluster resolution with clear allele discrimination, even with challenging SNP targets. Furthermore, it can be used in a liquid or lyophilized format to create ambient-temperature stable assays, making it ideal for point-of-care (POC) devices.

Two high-risk strains of HPV cause more than 70% of cervical cancers 1 but can be treated if detected early enough. The World Health Organization recommends DNA-based genotyping testing for HPV as the primary screening method to identify women who have or are at risk of cervical pre-cancer. Typically the test screens for fourteen different HPV types, including HPV type 16 and HPV type 18.

Immunoassay Solutions:

Meridian’s expertise in virology, cell culture, protein expression, and protein purification has enabled the company to be a leader in infectious disease for the past 40 years. With more than 3,000 antigens and antibodies covering more than 325 infectious diseases, cancer biomarkers, cardiac and metabolic disorders, hormone imbalances, and autoimmune diseases, the company offers one of the largest portfolios of antigens and antibodies designed for commercial diagnostic assays.

HIV

TARGET CAT. NO PRODUCT NAME P24 BN1045 Mab to HIV-1 P24 P24 BN1046 Mab to HIV-1 P24 P24 BN1018

EBV

TARGET CAT. NO PRODUCT NAME EBV-VCA gp125 8202

Viral gp125 Rec. Antigen

EBV Lysate (P3H3)

EBV

R02100

HIV-1 P24, Rec. Antigen, Group M, Subtype B (JRCSF)

EBV Nuclear Antigen-1 (EBNA-1) Rec. Antigen

EBV EBN A-1

HIV-1 gp41, Rec. Antigen, Group O (Cameroon) HIV-1 gp41, Rec. Antigen, Group O (Cameroon) HIV-1 gp36, Rec. Antigen, Subtype A (ST) HIV-1 gp36, Rec. Antigen, Subtype A (ST)

gp41

BN1019

R01522

gp41

BN1023

HBV

TARGET CAT. NO PRODUCT NAME HBsAg BN1215 HBsAg (adr), Rec. Ag HBsAg VTI610 HBsAg, Rec. Ag. HBsAg BN1231 mAb to HBsAg HBsAg BN1219 mAb to HBsAg HBsAg BN1097 mAb to HBsAg HBsAg BN1098 mAb to HBsAg HBsAg BN1099 mAb to HBsAg HBsAg BN1100 mAb to HBsAg TARGET CAT. NO PRODUCT NAME Core BN1102 Mab to Hepatits C Core BN1101

gp36

BN1021

gp36 BN1025

HIV-1 gp36, Rec. Antigen, Subtype A (ST)

gp36 BN1026

HIV-1 gp36, Rec. Ag, Subtype A (ROD), N-term His-Tag

gp36 BN1027

HPV

TARGET CAT. NO PRODUCT NAME HPV18 R01429 HPV18 L1, Rec Ag. HPV18 MAV56-965 mAb to HPV18, E6 HPV18 MAV56-267 mAb to HPV18, E6 HPV16 R01428 HPV16 L1, Rec Ag HPV16 MAV56-981 mAb to HPV16, L1 HPV16 MAV56-271 mAb to HPV16, E2 HTLV-1 TARGET CAT. NO PRODUCT NAME p24 R18152 HTLV-1 p24, Rec Ag. Env. Ag. R18142 HTLV-1 Env. Ag, Rec Ag. gp46 R01434 HTLV-1 gp46, Rec Ag. gp21 R01433 HTLV-1 gp21, Rec Ag. References: 1. https://www.who.int/europe/news/item/11-09-2021-who-recommends-dna- testing-as-a-first-choice-screening-method-for-cervical-cancer-prevention

HCV

Mab to Hepatits C (TBD) HCV Chimeric, Rec. Ag, NS3+Capsid, N-term His-Tag HCV Capsid, Rec. Ag, Subtype 1a HCV Capsid, Rec. Ag, Subtype 1b

Core/NS3

BN1032

Core

BN1031

Core

BN1033

HCV NS4, Rec. Ag

NS4

BN1216

Core/NS3/ NS4/NS5

HCV NS3/Core/NS4/NS5 Rec. Ag

BN1250

Ordering information: USA 5171 Wilfong Road Memphis, Tennessee 38134 Phone: +1 901-382-8716 Fax: +1 901-333-8223

Email: info@meridianlifescience.com Orders: orders@meridianlifescience.com www.meridianbioscience.com/lifescience

Connect with us:

ISO 13485 Certified

06/24

Powered by